AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)

AVAN 10.04

0.0%

Jun 12 9:41 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 613 who wrote (332)	6/30/2000 3:46:05 PM
From: John Romeo	Read Replies (1) of 513

From what I have heard the stock moved on news of the new Lilly sepsis drug success in phase III. Evidently there is some similarity to tp-10 in complement inhibition activity. Probably accounted for the 20% move Thursday and Fridays subsequent profit taking. Still holding over 10+ after dropping to 9 3/4 positive sign accumulation still underway.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next